All Stories

  1. Pharmacokinetics of Inter-Alpha Inhibitor Proteins and Effects on Hemostasis After Hypoxic-Ischemic Brain Injury in Neonatal Rats

    Article • Current Pharmaceutical Design, September 2020, Bentham Science Publishers

    William Jusko

  2. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids

    Article • Pharmacological Reviews, March 2020, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    William Jusko

  3. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part I: Determination and Prediction of Dexamethasone and Methylprednisolone Tissue Binding in the Rat

    Article • Journal of Pharmacology and Experimental Therapeutics, June 2019, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    William Jusko

  4. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression

    Article • Journal of Pharmacology and Experimental Therapeutics, June 2019, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    William Jusko

  5. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part III: Estrous Cycle and Estrogen Receptor–Dependent Antagonism of Glucocorticoid-Induced Leucine Zipper (GILZ) Enhancement by Corticosteroids

    Article • Journal of Pharmacology and Experimental Therapeutics, June 2019, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    William Jusko

  6. Modeling Corticosteroid Pharmacogenomics and Proteomics in Rat Liver

    Article • Journal of Pharmacology and Experimental Therapeutics, August 2018, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    William Jusko

  7. Modeling the Sex Differences and Interindividual Variability in the Activity of the Hypothalamic-Pituitary-Adrenal Axis

    Article • Endocrinology, August 2017, Endocrine Society

    William Jusko

  8. Modeling Combined Immunosuppressive and Anti-inflammatory Effects of Dexamethasone and Naproxen in Rats Predicts the Steroid-Sparing Potential of Naproxen

    Article • Drug Metabolism and Disposition, April 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    William Jusko

  9. Characterization and Interspecies Scaling of rhTNF-α Pharmacokinetics with Minimal Physiologically Based Pharmacokinetic Models

    Article • Drug Metabolism and Disposition, April 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    William Jusko

  10. Interrelationships between Infliximab and Recombinant Tumor Necrosis Factor-α in Plasma Using Minimal Physiologically Based Pharmacokinetic Models

    Article • Drug Metabolism and Disposition, April 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    William Jusko

  11. Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats

    Article • Drug Metabolism and Disposition, February 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    William Jusko

  12. Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis

    Article • Drug Metabolism and Disposition, February 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    William Jusko

  13. Variability in Zucker diabetic fatty rats: differences in disease progression in hyperglycemic and normoglycemic animals

    Article • Diabetes Metabolic Syndrome and Obesity, November 2014, Taylor & Francis

    Debra DuBois, William Jusko

  14. Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment

    Article • Diabetes Metabolic Syndrome and Obesity, August 2014, Dove Medical Press

    Debra DuBois, William Jusko